Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y) Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) Price to free cash flow

As of 25 September 2026, IDEXX Laboratories, Inc. (IDXX) trades at a price to free cash flow of 33.1×. Over the past ten years it has ranged from 32.2× (September 2026) to 112× (February 2023); the current reading is higher than 0% of that period. That is in line with the Diagnostics & Research industry median of 34.0× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 56.9× 20.30%
FY2024 47.3× (20.71%)
FY2023 59.6× (32.53%)
FY2022 88.4× (0.50%)
FY2021 88.8× 12.53%
FY2020 78.9× 4.17%
FY2019 75.8× 28.89%
FY2018 58.8× 25.89%
FY2017 46.7× 21.34%
FY2016 38.5× (20.93%)

Quarterly

Period Price to free cash flow Change
Jun 2026 33.6× (20.56%)
Mar 2026 42.3× (25.64%)
Dec 2025 56.9× (4.05%)
Sep 2025 59.3× (4.15%)
42 more quarters

Against its own ten years

Low 32.2× High 112×
Ten-year median 62.2×
Current reading's percentile 0

Price to free cash flow against peers

Company Price to free cash flow
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 19.4×
IQV IQVIA Holdings Inc. compare 19.9×
IDXX IDEXX Laboratories, Inc. 33.1×
MTD Mettler-Toledo International, Inc. compare 35.2×
A Agilent Technologies, Inc. compare 38.4×
ILMN Illumina, Inc. compare 44.9×
WAT Waters Corporation compare 116×
NTRA Natera, Inc. compare 702×
Diagnostics & Research industry median 34.0×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on IDXX